Zynerba reports 4Q loss

DEVON, Pa. (AP) _ Zynerba Pharmaceuticals Inc. (ZYNE) on Monday reported a loss of $8.1 million in its fourth quarter.

The Devon, Pennsylvania-based company said it had a loss of 60 cents per share.

The results exceeded Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 61 cents per share.

For the year, the company reported that its loss widened to $32 million, or $2.48 per share.

Zynerba shares have declined 27 percent since the beginning of the year. The stock has decreased 55 percent in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ZYNE at https://www.zacks.com/ap/ZYNE